Stem Cell-Based Approaches in Parkinson's Disease Research

Overview

Journal Int J Stem Cells

Date 2024 Mar 7

PMID 38449089

Authors

Min Seong Kim

Subeen Yoon

Jiwoo Choi

Yong Jun Kim

Gabsang Lee

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of midbrain dopaminergic neurons, leading to motor symptoms. While current treatments provide limited relief, they don't alter disease progression. Stem cell technology, involving patient-specific stem cell-derived neurons, offers a promising avenue for research and personalized regenerative therapies. This article reviews the potential of stem cell-based research in PD, summarizing ongoing efforts, their limitations, and introducing innovative research models. The integration of stem cell technology and advanced models promises to enhance our understanding and treatment strategies for PD.

Citing Articles

Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model.

Ye J, Sun X, Jiang Q, Gui J, Feng S, Qin B J Nanobiotechnology. 2024; 22(1):567.

PMID: 39277761 PMC: 11401276. DOI: 10.1186/s12951-024-02773-1.

Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond.

Tondo G, De Marchi F, Bonardi F, Menegon F, Verrini G, Aprile D J Clin Med. 2024; 13(11).

PMID: 38892809 PMC: 11172489. DOI: 10.3390/jcm13113098.

SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.

Lee B, Choi H, Che Y, Ko M, Seong H, Jo M Cell Rep Med. 2024; 5(5):101570.

PMID: 38749422 PMC: 11148862. DOI: 10.1016/j.xcrm.2024.101570.

References

Becerra-Calixto A, Mukherjee A, Ramirez S, Sepulveda S, Sinha T, Al-Lahham R . Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient. Cells. 2023; 12(4). PMC: 9954141. DOI: 10.3390/cells12040625. View

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

Zhao M, Momma S, Delfani K, Carlen M, Cassidy R, Johansson C . Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A. 2003; 100(13):7925-30. PMC: 164689. DOI: 10.1073/pnas.1131955100. View

Kim T, Piao J, Koo S, Kriks S, Chung S, Betel D . Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell. 2021; 28(2):343-355.e5. PMC: 8006469. DOI: 10.1016/j.stem.2021.01.005. View

Henderson M, Trojanowski J, Lee V . α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett. 2019; 709:134316. PMC: 7014913. DOI: 10.1016/j.neulet.2019.134316. View

Hallacli E, Kayatekin C, Nazeen S, Wang X, Sheinkopf Z, Sathyakumar S . The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 2022; 185(12):2035-2056.e33. PMC: 9394447. DOI: 10.1016/j.cell.2022.05.008. View

Liu G, David B, Trawczynski M, Fessler R . Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Stem Cell Rev Rep. 2019; 16(1):3-32. PMC: 6987053. DOI: 10.1007/s12015-019-09935-x. View

Woodard C, Campos B, Kuo S, Nirenberg M, Nestor M, Zimmer M . iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep. 2014; 9(4):1173-82. PMC: 4255586. DOI: 10.1016/j.celrep.2014.10.023. View

Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman B . Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci. 2011; 31(41):14508-20. PMC: 3587176. DOI: 10.1523/JNEUROSCI.1560-11.2011. View

10.

Basellini M, Kothuis J, Comincini A, Pezzoli G, Cappelletti G, Mazzetti S . Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery. Front Biosci (Landmark Ed). 2023; 28(2):33. DOI: 10.31083/j.fbl2802033. View

11.

Nolbrant S, Heuer A, Parmar M, Kirkeby A . Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation. Nat Protoc. 2017; 12(9):1962-1979. DOI: 10.1038/nprot.2017.078. View

12.

Freckelton I . Parkinson's Disease and the Criminal Justice System. J Law Med. 2022; 29(2):309-321. View

13.

Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B, Shukla P, Ali M . Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation. J Virol. 2017; 91(17). PMC: 5553188. DOI: 10.1128/JVI.00640-17. View

14.

Fernandez-Santiago R, Carballo-Carbajal I, Castellano G, Torrent R, Richaud Y, Sanchez-Danes A . Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients. EMBO Mol Med. 2015; 7(12):1529-46. PMC: 4693505. DOI: 10.15252/emmm.201505439. View

15.

Connolly B, Lang A . Pharmacological treatment of Parkinson disease: a review. JAMA. 2014; 311(16):1670-83. DOI: 10.1001/jama.2014.3654. View

16.

Volarevic V, Markovic B, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N . Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 2018; 15(1):36-45. PMC: 5765738. DOI: 10.7150/ijms.21666. View

17.

LeWitt P, Fahn S . Levodopa therapy for Parkinson disease: A look backward and forward. Neurology. 2016; 86(14 Suppl 1):S3-12. DOI: 10.1212/WNL.0000000000002509. View

18.

Kouroupi G, Taoufik E, Vlachos I, Tsioras K, Antoniou N, Papastefanaki F . Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease. Proc Natl Acad Sci U S A. 2017; 114(18):E3679-E3688. PMC: 5422768. DOI: 10.1073/pnas.1617259114. View

19.

Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram A, Karunakaran R . Alpha-Synuclein Aggregation in Parkinson's Disease. Front Med (Lausanne). 2021; 8:736978. PMC: 8558257. DOI: 10.3389/fmed.2021.736978. View

20.

Sullivan S, Stacey G, Akazawa C, Aoyama N, Baptista R, Bedford P . Quality control guidelines for clinical-grade human induced pluripotent stem cell lines. Regen Med. 2018; 13(7):859-866. DOI: 10.2217/rme-2018-0095. View